Evidence map›Paper›PMID 41265425›Full record

ArticleHealthcare informatics research2025

Deep Learning-Based Death Prediction Model for Chronic Kidney Disease.

Hyeji Kim, Hyekyung Woo

Abstract read
In one paragraph

Article in Healthcare informatics research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hyeji KimDepartment of Health Administration, Kongju National University, Gongju, Korea.
Hyekyung WooDepartment of Health Administration, Kongju National University, Gongju, Korea.

Funding

Kongju National UniversityNational Research Foundation of Korea 2020R1C1C1009679
6 · The paper itself

Abstract

objectivesThe prevalence of chronic kidney disease (CKD) continues to rise, making it one of the leading causes of death worldwide. Recent advances in medical and health research have progressed beyond traditional statistical methodologies, increasingly leveraging artificial intelligence to identify and predict factors influencing mortality. Further AI-based research is therefore essential to deepen understanding of the determinants of death among CKD patients.

methodsThis study used data from the Korea Disease Control and Prevention Agency's in-depth survey of patients discharged between 2016 and 2021. Least absolute shrinkage and selection operator (LASSO) regression, a machine learning technique, was applied to identify significant factors associated with death in CKD patients. These selected variables were then incorporated into a deep learning-based predictive model.

resultsEight factors influencing death were identified, including length of hospital stay (coefficient = 0.023), emergency admission (0.016), age (0.013), severity-adjusted score (0.008), and regional differences (0.003). The developed deep learning model achieved a loss value of 0.1207 and an accuracy of 96.84%.

conclusionsThis study identified emergency visits and prolonged hospital stays as key predictors of death in CKD patients. To mitigate these risks, regular monitoring by nephrology specialists and timely initiation of renal replacement therapy are essential. Age also emerged as a critical determinant, emphasizing the importance of age-stratified clinical guidelines amid global aging trends. The high-performing, simplified predictive model based on general characteristics offers a valuable tool for rapid prognosis assessment in primary and secondary healthcare settings.

Indexed as

ChronicDeep LearningMachine LearningPrediction AlgorithmsRenal InsufficiencyRisk Factors

Identifiers

PMID41265425
PMCPMC12640731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.